Kidney problems linked to tenofovir use, improve with switch to abacavir
Stigma, delay and misunderstanding slow access to ART in Africa
Scientists and clinicians must challenge HIV-related stigma and ensure enabling legal and policy environments, IAS conference hears
Efavirenz in children: WHO dosing guidelines raise the risk of side-effects in Thai children
Non-African middle-income countries pay four times more for ARVs than African middle-income countries
Darunavir/ritonavir safe and effective for younger children
Lower-dose lopinavir/ritonavir reduces side-effects, maintains viral control in Thai children
Magical thinking? FEM-PrEP trial may have failed because participants used testing as prevention
Malaysia’s harm reduction programmes are preventing infections and saving money, but reaching far too few people who inject drugs
